Morinaga M-16V by MayPro Industries
Morinaga M-16V by MayPro Industries
Morinaga M-16V by MayPro Industries is a clinically validated, room-temperature-stable strain of Bifidobacterium breve supported by over 30 published studies, including 19 human trials. Extensively used in neonatal intensive care units across Japan, it helps restore gut Bifidobacterium levels and supports immune, respiratory, and skin health in infants and children. The strain is FDA GRAS approved, Non-GMO, Halal, and Dairy-Free, ensuring exceptional stability and safety for applications in infant nutrition and digestive health formulations.
General
Item #:
Company:
Technology:
Room-temperature-stable probiotic strain
Name:
Morinaga M-16V
Ingredient/s:
Bifidobacterium breve
Categories:
Digestive Health, Immunity Health
Dosage (min):
Dosage (max):
100 billion CFU
Price kg:
Request Info
MOQ:
Botanical Names:
Bifidobacterium breve
Active/s:
Bifidobacterium breve
Assay:
≥1 billion CFU/g
Country of Origin:
Japan
Suppliers:
MayPro Industries
Contact Information
Email:
Documents (Coming Soon)
Upgrade your account to access documents
COMING SOON
Ingredient Overview
Cheat Sheet Card
100% Natural
Vegan
Gluten Free
Non-GMO
GRAS
Water Soluble
Wild-Harvested
Allergen Free
Key Certifications
Halal Certified
Kosher Certified
Vegan Certified
USDA Organic
NON-GMO Project Verified
Gluten-Free Certified
Send an Inquiry
Featured Ingredients
Ingredient Highlights
Morinaga M-16V features clinically supported actives shown to help:
- Support gut colonization in infants and children.
- Promote immune development and balance in early life.
- Aid intestinal barrier integrity and function.
- Support microbial balance during early stages of life.
- Enhance resilience to environmental immune challenges.
- Support gut-brain-immune connection in infancy.
- Promote healthy GI flora in pediatric populations.*
Featured Content
Product type
Related Articles
